Information
-
Trademark
-
86923538
-
Serial Number
86923538
-
Registration Number
5324651
-
International Classifications
-
Filing Date
February 29, 2016
8 years ago
-
Registration Date
October 31, 2017
7 years ago
-
Transaction Date
October 06, 2023
a year ago
-
Status Date
October 05, 2023
a year ago
-
Published for Opposition Date
January 03, 2017
7 years ago
-
Location Date
October 05, 2023
a year ago
-
First Use Anywhere Date
June 22, 2015
9 years ago
-
First Use In Commerce Date
March 31, 2016
8 years ago
-
Status Code
701
-
Current Location
TMO LAW OFFICE 111
Employee Name
FOSDICK, GEOFFREY A
-
Law Office Assigned Location Code
M20
-
Owners
Mark Drawing Code
3000
Mark Identification
Z
Case File Statements
- DM0000: The mark consists of a orange colored shield with the letter "Z" included in the shield in white.
- CC0000: The color(s) orange, and white is/are claimed as a feature of the mark.
- GS0421: Bacteriological consultation and research; Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting clinical trials for others in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Development of pharmaceutical preparations and medicines; Diagnostic services in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Drug discovery services; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genotyping services for research or analysis purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research information in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research services in the field of cancer; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of oncology; Scientific study and research in the field(s) of rheumatoid arthritis; Scientific study and research in the field(s) of diabetes; Scientific study and research in the field(s) of metabolic disorders; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
Case File Event Statements
-
10/5/2023 - a year ago
29 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Type: NAS8
-
10/5/2023 - a year ago
28 - REGISTERED - SEC. 8 (6-YR) ACCEPTED
Type: 8.OK
-
10/5/2023 - a year ago
27 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
5/26/2023 - a year ago
26 - TEAS SECTION 8 RECEIVED
Type: ES8R
-
10/31/2022 - 2 years ago
25 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1
-
10/31/2017 - 7 years ago
24 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
9/27/2017 - 7 years ago
23 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA
-
9/26/2017 - 7 years ago
22 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
9/20/2017 - 7 years ago
21 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
8/28/2017 - 7 years ago
20 - USE AMENDMENT FILED
Type: IUAF
-
9/14/2017 - 7 years ago
19 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
8/28/2017 - 7 years ago
18 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
2/28/2017 - 7 years ago
17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
1/3/2017 - 7 years ago
16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
1/3/2017 - 7 years ago
15 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
12/14/2016 - 8 years ago
14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
11/29/2016 - 8 years ago
13 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
11/23/2016 - 8 years ago
12 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
11/22/2016 - 8 years ago
11 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
11/22/2016 - 8 years ago
10 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
11/8/2016 - 8 years ago
9 - ASSIGNED TO LIE
Type: ALIE
-
10/28/2016 - 8 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/10/2016 - 8 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/10/2016 - 8 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/10/2016 - 8 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/10/2016 - 8 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/4/2016 - 8 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
3/3/2016 - 8 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
3/3/2016 - 8 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP